Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00725946 | Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT | terminated | Early Phase 1 | 7 | Stanford UniversityOTHER | 1 | Oct 11, 2017 | clinicaltrials |
| NCT02863146 | Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer | terminated | — | 23 | Centre Oscar LambretOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT01939418 | Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 23 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 3, 2017 | clinicaltrials |
| NCT00003454 | Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer | terminated | Phase 2 | 19 | Burzynski Research InstituteOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00684216 | Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer | terminated | Phase 2 / Phase 3 | 10 | The Netherlands Cancer InstituteOTHER | 1 | Sep 14, 2017 | clinicaltrials |
| NCT00754767 | L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer | terminated | Phase 4 | 2 | HealthPartners InstituteOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT02712437 | Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer | terminated | N/A | 4 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 8, 2017 | clinicaltrials |
| NCT00832338 | Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores | terminated | Phase 2 | 23 | Emory UniversityOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT01319539 | MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | terminated | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01351844 | The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer(CEASE) | terminated | N/A | 12 | George Washington UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT02360059 | Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 17, 2017 | clinicaltrials |
| NCT02074878 | CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer(CRIZENT) | terminated | Phase 1 | 3 | Mothaffar RimawiOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT01114256 | FNA Tumor Sampling for CD137 Modulation: A Pilot Study | terminated | — | 83 | Stanford UniversityOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT00206492 | Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients | terminated | Phase 2 | 3 | Baylor Breast Care CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00899197 | Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer | terminated | — | 2 | Wake Forest University Health SciencesOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01436604 | Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging(MRTOX) | terminated | Phase 2 | 19 | Centre Francois BaclesseOTHER | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02040493 | Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer | terminated | N/A | 75 | Xoft, Inc.INDUSTRY | 1 | Jul 25, 2017 | clinicaltrials |
| NCT01847599 | Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib(ProMETheX) | terminated | N/A | 65 | Centre Jean PerrinOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT00041470 | Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial | terminated | Phase 1 / Phase 2 | 38 | University of WashingtonOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00194792 | Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer | terminated | Phase 2 | 28 | University of WashingtonOTHER | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01754519 | Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery | terminated | Phase 2 | 1 | Roswell Park Cancer InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01222416 | PET/CT Evaluation of Treatment Response in Breast Cancer | terminated | N/A | 50 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01918306 | GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT01868503 | Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer | terminated | Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 26, 2017 | clinicaltrials |
| NCT00088985 | Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT00932035 | Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 39 | City of Hope Medical CenterOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT00959985 | Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer | terminated | N/A | 23 | Massachusetts General HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT02322853 | A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors(OLYMPE) | terminated | Phase 2 | 8 | Centre Francois BaclesseOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00900068 | Blood Samples From Patients on a Clinical Trial to CINV During HSCT | terminated | — | 9 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02483377 | Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer | terminated | — | 13 | University of Southern CaliforniaOTHER | 1 | Apr 20, 2017 | clinicaltrials |
| NCT02217033 | Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant Chemo | terminated | N/A | 16 | South Sound Care FoundationOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT02370264 | Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer | terminated | N/A | 36 | University of Southern CaliforniaOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT00661531 | Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy | terminated | Phase 2 | 11 | Georgetown UniversityOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01151449 | Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01729884 | Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer | terminated | Phase 2 | 3 | University of WashingtonOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00126451 | A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) | terminated | Phase 2 | 16 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Apr 10, 2017 | clinicaltrials |
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | terminated | Phase 2 | 31 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00496366 | Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer | terminated | Phase 2 | 11 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00285857 | Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention | terminated | Phase 2 | 30 | Stanford UniversityOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT02144012 | A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer | terminated | Phase 3 | 49 | Hoffmann-La RocheINDUSTRY | 4 | Mar 7, 2017 | clinicaltrials |
| NCT01120158 | Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer | terminated | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01562873 | Ruxolitinib in Patients With Breast Cancer | terminated | Phase 2 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00904423 | Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption | terminated | Phase 1 / Phase 2 | 8 | Mark PegramOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00133796 | Neoadjuvant Herceptin in Patients With Breast Cancer | terminated | Phase 2 | 40 | Mothaffar RimawiOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00481845 | Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer | terminated | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01856036 | Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers | terminated | N/A | 2 | Saint John's Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00087620 | A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer | terminated | Phase 4 | — | Hoffmann-La RocheINDUSTRY | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00946283 | Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome | terminated | N/A | 30 | Rutgers, The State University of New JerseyOTHER | 1 | Feb 3, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2017source: clinicaltrials